BIOLOGICAL TESTING FACILITY - CONTRACEPTIVE RESEARCH AND DEVELOPMENT TASK ORDER

生物测试设施 - 避孕药研发任务单

基本信息

  • 批准号:
    10263608
  • 负责人:
  • 金额:
    $ 148.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-04 至 2022-09-03
  • 项目状态:
    已结题

项目摘要

Within the Division of Intramural Population Health Research (DIPHR), the Contraceptive Development Program (CDP) at NICHD supports research to develop compounds that can disrupt normal ovulation, sperm production or sperm function for the purpose of developing safe, effective and affordable contraceptives for men or women. The Biological Testing Facility (BTF) is designed to allow rapid evaluation of new compositions-of-matter, drug formulations, delivery systems, and devices for contraceptive and endocrine activity. The BTF provides overall project management and the capabilities to support all phases of preclinical activities pursuant to development of new contraceptive methods: these include, but are not limited to in vitro and in vivo assays, plasma and microsomal stability studies, absorption, distribution, metabolism, excretion and toxicity (ADMET), pharmacokinetic (PK) and pharmacodynamic (PD) profiling, animal activities and studies, manufacture of active pharmaceutical ingredients (APIs), process and product development, formulation, clinical lot production, preclinical enabling studies and associated tasks leading to the filing of investigational new drug (IND) applications. Compounds formulated by the BTF are, or will be, tested in non-human primates. NICHD maintains a colony of non-human primates for the purpose of evaluating potential contraceptive agents prior to trials in human subjects. Compounds formulated by the BTF that are prepared under current Good Manufacturing Practices (cGMP) will allow clinical evaluation in the CDP Contraceptive Clinical Trials Network (CCTN). The CCTN investigators have develop protocols to evaluate the drug candidates identified as high priority by the Program. The BTF has been working with the CORs for the Chemical Synthesis Facility and the CCTN and with the investigators in the CCTN to develop and test the appropriate formulations for clinical batches of the candidate compounds. The next clinical study for each candidate drug is dependent on timely receipt of clinical batches to begin the process of recruitment and enrollment. Drugs that are currently in ongoing clinical of the clinical formulations. The Biological Testing Facility plays a critical role in the drug development mission of the CDP.
在内部人口健康研究司(DIPHR)内,避孕药具 NICHD的开发计划(CDP)支持研究开发可能破坏正常的化合物 排卵、精子产生或精子功能,以发展安全、有效和 男性或女性负担得起的避孕药具。生物检测设施(BTF)是 旨在允许快速评估新的物质成分、药物配方、给药 用于避孕和内分泌活动的系统和设备。北京交流会提供总体项目 管理和能力,以支持临床前活动的所有阶段 开发新的避孕方法:这些方法包括但不限于体外和体外 活体分析、血浆和微粒体稳定性研究、吸收、分布、 代谢、排泄和毒性(ADMET)、药代动力学(PK)和药效学(PD) 简介、动物活动和研究、活性药物成分(原料药)的制造、 流程和产品开发、配方、临床批量生产、临床前支持 导致提交研究新药(IND)申请的研究和相关任务。 BTF配制的化合物正在或将在非人类灵长类动物身上进行测试。NICHD保持着 非人灵长类动物群体,用于评估潜在的避孕药 人体受试者的试验。由BTF配制的化合物,根据以下条件制备 目前的良好生产规范(CGMP)将允许对CDP避孕药进行临床评估 临床试验网络(CCTN)。CCTN的调查人员已经制定了评估药物的方案 被该计划确定为高优先级的候选人。BTF一直在与CORS合作 化学合成设施和CCTN以及CCTN的调查人员 为候选化合物的临床批次开发和测试合适的配方。这个 每种候选药物的下一步临床研究取决于是否及时收到临床批次 开始招聘和注册流程。目前正在进行临床试验的药物 临床配方中的。生物检测机构扮演着一个 在CDP的药物开发任务中发挥关键作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TOUFAN PARMAN其他文献

TOUFAN PARMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TOUFAN PARMAN', 18)}}的其他基金

BIOLOGICAL TESTING FACILITY - "RESEARCH AND DEVELOPMENT OF PRECLINICAL CONTRACEPTIVES".
生物测试设施 - “临床前避孕药的研究和开发”。
  • 批准号:
    10352181
  • 财政年份:
    2020
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - ADMINISTRATIVE / MANAGEMENT / DATABASE TASK ORDER
生物检测设施 - 行政/管理/数据库任务单
  • 批准号:
    10927162
  • 财政年份:
    2020
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - CONTRACEPTIVE RESEARCH AND DEVELOPMENT TASK ORDER
生物测试设施 - 避孕药研发任务单
  • 批准号:
    10390264
  • 财政年份:
    2020
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - "RESEARCH AND DEVELOPMENT OF PRECLINICAL CONTRACEPTIVES".
生物测试设施 - “临床前避孕药的研究和开发”。
  • 批准号:
    10183638
  • 财政年份:
    2020
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - "CONTRACEPTIVE DRUG AND INTRAVAGINAL CONTRACEPTIVE DEVICE EVALUATION"
生物测试设施 - “避孕药物和阴道内避孕器具评估”
  • 批准号:
    10271538
  • 财政年份:
    2020
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - ADMINISTRATIVE / MANAGEMENT / DATABASE TASK ORDER
生物检测设施 - 行政/管理/数据库任务单
  • 批准号:
    10263606
  • 财政年份:
    2020
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - FORMULATION DEVELOPMENT CLINICAL MANUFACTURING AND STABILITY TESTING
生物测试设施 - 制剂开发、临床制造和稳定性测试
  • 批准号:
    10266724
  • 财政年份:
    2019
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - RESEARCH AND DEVELOPMENT OF PRECLINICAL CONTRACEPTIVES
生物测试设施 - 临床前避孕药的研究和开发
  • 批准号:
    10013411
  • 财政年份:
    2019
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - CHARACTERIZATION OF POTENTIAL OVULATION INHIBITORS
生物测试设施 - 潜在排卵抑制剂的表征
  • 批准号:
    10021077
  • 财政年份:
    2019
  • 资助金额:
    $ 148.67万
  • 项目类别:
BIOLOGICAL TESTING FACILITY - FORMULATION DEVELOPMENT CLINICAL MANUFACTURING AND STABILITY TESTING
生物测试设施 - 制剂开发、临床制造和稳定性测试
  • 批准号:
    10013413
  • 财政年份:
    2019
  • 资助金额:
    $ 148.67万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 148.67万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
  • 批准号:
    23KK0126
  • 财政年份:
    2023
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 148.67万
  • 项目类别:
    Training Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了